Skip to main content

Table 2 Comparison of clinical symptoms of patients with F-CI, N-CI and N-FCI at the first treatment

From: Transcranial sonography with clinical and demographic characteristics to predict cognitive impairment in PD: a longitudinal study

Clinical symptoms

F-CI (n = 58)

N-FCI (n = 114)

N-CI (n = 48)

P1

P2

MS

 Bradykinesia

58

114

48

NA

NA

 Rest tremor

49

98

41

0.794c

0.894c

 Rigidity

36

66

31

0.598c

0.789c

Mental symptoms

 Memory deficit

31

48

18

0.158c

0.101c

 RCP

5

12

3

0.692c

0.928e

 Cognitive impairment

58

0

0

NA

NA

 Somnipathy

14

17

7

0.137c

0.219c

 Anxiety

25

41

13

0.363c

0.087c

 Depression

21

36

9

0.542c

0.047c

 Apathy

5

6

2

0.395c

0.599e

Autonomic symptoms

 Constipation

33

71

26

0.495c

0.778c

 Hyperhidrosis

2

1

1

0.547e

NA*

 Postural hypotension

10

19

6

0.924c

0.497c

 Dysuria

31

57

23

0.669c

0.571c

 Salivation

11

15

4

0.315c

0.199e

 Sexual dysfunction

5

13

9

0.573c

0.125c

Sensory disturbance

 Olfactory dysfunction

18

36

20

0.942c

0.256c

 Pain

11

19

8

0.707c

0.759c

 Spasm

0

1

1

NA

NA

 Numbness

1

5

2

0.646e

0.868c

 RLS

2

4

1

NA*

NA*

  1. P1: Comparison of MS and NMS between F-CI and N-FCI at the first treatment
  2. P2: Comparison of MS and NMS between F-CI and N-CI at the first treatment
  3. RLS Restless legs syndrome, MS Motor symptoms, RCP Reduced computing power, NA Not available
  4. NA* Not available after continuity correction, P = 1
  5. cChi square test
  6. eContinuity correction of chi square test